Challenges for women in Neurology
The aim of the event is to help identify and overcome the challenges that women may find during their academic and hospital career development in neurology. This event is mainly directed to female neurology residents and female neurologists at the beginning of their Career, but certainly men are more than welcome to attend. Understanding the challenges that women face is also important for their male colleagues, mentors and Chiefs.
You are invited to bring your lunch to this session.
Elena Moro, France and Antonella Macerollo, United Kingdom
Barbara Tettenborn is Head of the Department of Neurology at Kantonspital St. Gallen, Switzerland, and teaches at the Johannes Gutenberg Universität Mainz, Germany, and the University Hospital Zürich, Switzerland. She is an author of several book chapters in the fields of general neurology, epileptology, stroke and sports medicine, and editor of numerous neurological books and texbooks. Her Scientific main focuses are Epilepsy, Stroke, Dementia, Sport Neurology, Neurophysiology, and neurovascular diseases. She is president of the Women in Neurology (WIN) group of the Swiss Neurological Society and of the Swiss League against Epilepsy. She also is on the Board of the Swiss Federation of Clinical Neuro-Societies (SFCNS) and is EAN’s Editor-in-Chief of eLearning.
Baroness Greenfield, Founder and CEO of Neuro-Bio Ltd is a neuroscientist, writer and broadcaster. She has published over 200 papers in peer-reviewed journals, based mainly at Oxford University but has held research fellowships at the College de France Paris, NYU Medical Center New York and Melbourne University. She holds 32 honorary degrees from UK and foreign universities, has received numerous honours including the Legion d’Honneur from the French Government, an Honorary Fellowship from the Royal College of Physicians, The American Academy of Achievement Golden Plate Award, and The Australian Medical Research Society Medal. She is also a Fellow of the Royal Society of Edinburgh.
Maria Judit Molnar is director of the Institute of Genomic Medicine and Rare Disorders at Semmelweis University, Budapest. She is recognised as a leading expert on the diagnosis and treatment of rare neurological and especially rare neurogenetic (neuromuscular) disorders. Her research covers a broad range of basic and clinical studies on rare neurological disorders, utilising a broad spectrum of technologies, including clinical science, histology, cytochemistry, molecular biology and genetics. She is president of the Hungarian Medical College of Clinical Genetics, past president of the Hungarian Society of Clinical Neurogenetics, secretary of the Hungarian Society of Personalized Medicine, and a member of the Neurogenetic and Neuromuscular Committee of the European Academy of Neurology.